Importance of DNA damage checkpoints in the pathogenesis of human cancers

被引:63
作者
Poehlmann, Angela [1 ]
Roessner, Albert [1 ]
机构
[1] Otto VonGuericke Univ Magdegurg, Dept Pathol, D-39120 Magdeburg, Germany
关键词
DNA damage response (DDR); Cell cycle; Checkpoint control; Cancer; Cell cycle regulators; MAPK's; CELL-CYCLE ARREST; EARLY EMBRYONIC LETHALITY; ATM SEQUENCE VARIANTS; XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAKS; POLO-LIKE KINASE; ATAXIA-TELANGIECTASIA; PROSTATE-CANCER; INDUCED PHOSPHORYLATION; TUMOR-SUPPRESSOR;
D O I
10.1016/j.prp.2010.06.006
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
All forms of life on earth must cope with constant exposure to DNA-damaging agents that may promote cancer development. As a biological barrier, known as DNA damage response (DDR), cells are provided with both DNA repair mechanisms and highly conserved cell cycle checkpoints. The latter are responsible for the control of cell cycle phase progression with ATM, ATR, Chk1, and Chk2 as the main signaling molecules, thus dealing with both endogenous and exogenous sources of DNA damage. As cell cycle checkpoint and also DNA repair genes, such as BRCA1 and BRCA2, are frequently mutated, we here discuss their fundamental roles in the pathogenesis of human cancers. Importantly, as current evidence also suggests a role of MAPK's (mitogen activated protein kinases) in cell cycle checkpoint control, we describe in this review both the ATR/ATM-Chk1/Chk2 signaling pathways as well as the regulation of cell cycle checkpoints by MAPK's as molecular mechanisms in DDR, and how their dysfunction is related to cancer development. Moreover, since damage to DNA might be the common underlying mechanism for the positive outcome of chemotherapy, we also discuss targeting anticancer treatments on cell cycle checkpoints as an important issue emerging in drug discovery. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:591 / 601
页数:11
相关论文
共 164 条
[1]   Cell cycle checkpoint signaling through the ATM and ATR kinases [J].
Abraham, RT .
GENES & DEVELOPMENT, 2001, 15 (17) :2177-2196
[2]   ATM and breast cancer susceptibility [J].
Ahmed, M. ;
Rahman, N. .
ONCOGENE, 2006, 25 (43) :5906-5911
[3]   ATM polymorphisms as risk factors for prostate cancer development [J].
Angèle, S ;
Falconer, A ;
Edwards, SM ;
Dörk, T ;
Bremer, M ;
Moullan, N ;
Chapot, B ;
Muir, K ;
Houlston, R ;
Norman, AR ;
Bullock, S ;
Hope, Q ;
Meitz, J ;
Dearnaley, D ;
Dowe, A ;
Southgate, C ;
Ardern-Jones, A ;
Easton, DF ;
Eeles, RA ;
Hall, J .
BRITISH JOURNAL OF CANCER, 2004, 91 (04) :783-787
[4]   CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? [J].
Antoni, Laurent ;
Sodha, Nayanta ;
Collins, Ian ;
Garrett, Michelle D. .
NATURE REVIEWS CANCER, 2007, 7 (12) :925-936
[5]   Cell Cycle Control by the CDC25 Phosphatases [J].
Aressy, Bernadette ;
Ducommun, Bernard .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (08) :818-824
[6]   Enhanced phosphorylation of p53 by ATN in response to DNA damage [J].
Banin, S ;
Moyal, L ;
Shieh, SY ;
Taya, Y ;
Anderson, CW ;
Chessa, L ;
Smorodinsky, NI ;
Prives, C ;
Reiss, Y ;
Shiloh, Y ;
Ziv, Y .
SCIENCE, 1998, 281 (5383) :1674-1677
[7]   Atm-deficient mice: A paradigm of ataxia telangiectasia [J].
Barlow, C ;
Hirotsune, S ;
Paylor, R ;
Liyanage, M ;
Eckhaus, M ;
Collins, F ;
Shiloh, Y ;
Crawley, JN ;
Ried, T ;
Tagle, D ;
WynshawBoris, A .
CELL, 1996, 86 (01) :159-171
[8]   Mammalian G1- and S-phase checkpoints in response to DNA damage [J].
Bartek, J ;
Lukas, J .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (06) :738-747
[9]   Chk1 and Chk2 kinases in checkpoint control and cancer [J].
Bartek, J ;
Lukas, J .
CANCER CELL, 2003, 3 (05) :421-429
[10]   DNA damage response as an anti-cancer barrier - Damage threshold and the concept of 'conditional haploinsufficiency' [J].
Bartek, Jiri ;
Lukas, Jiri ;
Bartkova, Jirina .
CELL CYCLE, 2007, 6 (19) :2344-2347